المؤلفون: Pagliuca F., Zito Marino F., Morgillo F., della Corte C., Santini M., Vicidomini G., Guggino G., de Dominicis G., Campione S., Accardo M., Cozzolino I., Franco R.

المساهمون: Pagliuca, F., Zito Marino, F., Morgillo, F., della Corte, C., Santini, M., Vicidomini, G., Guggino, G., de Dominicis, G., Campione, S., Accardo, M., Cozzolino, I., Franco, R.

المصدر: European review for medical and pharmacological sciences. 25(12)

مصطلحات موضوعية: Mesothelioma, Male, BAP1-related tumour predisposition syndrome, Tumor Suppressor Proteins, Mesothelioma, Malignant, Humans, BAP1, Female, Genetic Predisposition to Disease, Middle Aged, Ubiquitin Thiolesterase, Germ-Line Mutation, Aged

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::0df5a12b157e3ba6deb74d3d9b53fba4Test
https://pubmed.ncbi.nlm.nih.gov/34227091Test

المؤلفون: Morabito A., Piccirillo M. C., Maione P., Luciani A., Cavanna L., Bonanno L., Filipazzi V., Leo S., Cinieri S., Morgillo F., Burgio M. A., Ferrara D., Rosetti F., Bianco R., Artioli F., Cortinovis D., Gebbia V., Fregoni V., Mencoboni M., Sandomenico C., Rossi A., Montanino A., Manzo A., Rocco G., Arenare L., Daniele G., Signoriello S., Gallo C., Perrone F., Gridelli C.

المساهمون: Morabito, A., Piccirillo, M. C., Maione, P., Luciani, A., Cavanna, L., Bonanno, L., Filipazzi, V., Leo, S., Cinieri, S., Morgillo, F., Burgio, M. A., Ferrara, D., Rosetti, F., Bianco, R., Artioli, F., Cortinovis, D., Gebbia, V., Fregoni, V., Mencoboni, M., Sandomenico, C., Rossi, A., Montanino, A., Manzo, A., Rocco, G., Arenare, L., Daniele, G., Signoriello, S., Gallo, C., Perrone, F., Gridelli, C.

مصطلحات موضوعية: Cisplatin, Elderly patient, NSCLC, Phase 3, Quality of life, Randomized, Aged, 80 and over, Alopecia, Antineoplastic Combined Chemotherapy Protocol, Carcinoma, Non-Small-Cell Lung, Female, Human, Lung Neoplasm, Male, Neoplasm Staging, Stomatitis, Aphthou, Surveys and Questionnaire, Treatment Outcome

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000474326700011; volume:133; firstpage:62; lastpage:68; numberofpages:7; journal:LUNG CANCER; http://hdl.handle.net/11588/823694Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85065520913

الإتاحة: https://doi.org/10.1016/j.lungcan.2019.05.009Test
http://hdl.handle.net/11588/823694Test

المؤلفون: Garassino M. C., Crino L., Catino A., Ardizzoni A., Cortesi E., Cappuzzo F., Bordi P., Calabro L., Barbieri F., Santo A., Altavilla G., Ambrosio F., Mini E., Vasile E., Morgillo F., Scoppola A., Bengala C., Follador A., Tedde N., Giannarelli D., Lo Russo G., Vitiello F.

المساهمون: Garassino, M. C., Crino, L., Catino, A., Ardizzoni, A., Cortesi, E., Cappuzzo, F., Bordi, P., Calabro, L., Barbieri, F., Santo, A., Altavilla, G., Ambrosio, F., Mini, E., Vasile, E., Morgillo, F., Scoppola, A., Bengala, C., Follador, A., Tedde, N., Giannarelli, D., Lo Russo, G., Vitiello, F.

مصطلحات موضوعية: Expanded access program, Italian, never-smoker, nivolumab, squamous non-small cell lung cancer, Adult, Aged, 80 and over, Carcinoma, Non-Small-Cell Lung, Squamous Cell, Case-Control Studie, Cohort Studie, Disease Progression, Female, Follow-Up Studie, Human, Lung Neoplasm, Male, Middle Aged, Non-Smoker, Prognosi, Survival Rate, Health Services Accessibility

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30486741; volume:40; issue:11; firstpage:1010428318815047; journal:TUMOR BIOLOGY; http://hdl.handle.net/11591/424047Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85057530732; http://journals.sagepub.com/loi/tubTest

الإتاحة: https://doi.org/10.1177/1010428318815047Test
http://hdl.handle.net/11591/424047Test
http://journals.sagepub.com/loi/tubTest

المؤلفون: Di Maio, M, Leighl, Nb, Gallo, C, Feld, R, Ciardiello, F, Butts, C, Maione, P, Gebbia, V, Morgillo, F, Wierzbicki, R, Favaretto, A, Alam, Y, Cinieri, S, Siena, S, Bianco, R, Riccardi, F, Spatafora, M, Ravaioli, A, Felletti, R, Fregoni, V, Genestreti, G, Rossi, A, Mancuso, G, Fasano, M, Morabito, A, Tsao, Ms, Signoriello, S, Perrone, F, Gridelli, C, Torch, Investigators, Calabro', L

المساهمون: Di Maio, M., Leighl, N. B., Gallo, C., Feld, R., Ciardiello, F., Butts, C., Maione, P., Gebbia, V., Morgillo, F., Wierzbicki, R., Favaretto, A., Alam, Y., Cinieri, S., Siena, S., Bianco, Roberto, Riccardi, F., Spatafora, M., Ravaioli, A., Felletti, R., Fregoni, V., Genestreti, G., Rossi, A., Mancuso, G., Fasano, M., Morabito, A., Tsao, M. S., Signoriello, S., Perrone, F., Gridelli, C., Di Maio, M, Leighl, N, Gallo, C, Feld, R, Ciardiello, F, Butts, C, Maione, P, Gebbia, V, Morgillo, F, Wierzbicki, R, Favaretto, A, Alam, Y, Cinieri, S, Siena, S, Bianco, R, Riccardi, F, Spatafora, M, Ravaioli, A, Felletti, R, Fregoni, V, Genestreti, G, Rossi, A, Mancuso, G, Fasano, M, Morabito, A, Tsao, M, Signoriello, S, Perrone, F, Gridelli, C, Leighl, Nb

مصطلحات موضوعية: Oncology, Male, erlotinib, Lung Neoplasms, Health-related quality of life, NSCLC, chemotherapy, Deoxycytidine, law.invention, Randomized controlled trial, Quality of life, law, Carcinoma, Non-Small-Cell Lung, Surveys and Questionnaires, Antineoplastic Combined Chemotherapy Protocols, Surveys and Questionnaire, Quality of life analysis of TORCH, Erlotinib Hydrochloride, Prognosis, humanities, Research Design, Advanced non–small-cell lung cancer, Carcinoma, Squamous Cell, Female, Erlotinib, Randomized trial, medicine.drug, Human, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Prognosi, EGFR, First-line treatment, first-line erlotinib, second-line cisplatin/gemcitabine chemotherapy, Adenocarcinoma, NO, Follow-Up Studie, Internal medicine, advanced non-small-cell lung cancer, medicine, Humans, Lung cancer, Advanced non-small-cell lung cancer, Chemotherapy, Quality of life analysis of TORCH , first-line erlotinib , second-line cisplatin/gemcitabine chemotherapy, advanced non-small-cell lung cancer, Aged, Neoplasm Staging, Salvage Therapy, Antineoplastic Combined Chemotherapy Protocol, business.industry, Questionnaire, Cancer, Quinazoline, medicine.disease, Interim analysis, Gemcitabine, Surgery, Lung Neoplasm, quality of life, Quinazolines, Carcinoma, Large Cell, Cisplatin, Neoplasm Recurrence, Local, business, Follow-Up Studies

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::297e0496785c9c52225a929dbddaa27eTest
http://hdl.handle.net/11588/519780Test

المؤلفون: Di Maio M, Leighl NB, Gallo C, Feld R, Ciardiello F, Butts C, Maione P, Gebbia V, Morgillo F, Wierzbicki R, Favaretto A, Alam Y, Cinieri S, Siena S, Bianco R, Riccardi F, Spatafora M, Ravaioli A, Felletti R, Fregoni V, Genestreti G, Rossi A, Mancuso G, Fasano M, Morabito A, Tsao MS, Signoriello S, Perrone F, Gridelli C

المساهمون: Di Maio, M, Leighl, Nb, Gallo, C, Feld, R, Ciardiello, F, Butts, C, Maione, P, Gebbia, V, Morgillo, F, Wierzbicki, R, Favaretto, A, Alam, Y, Cinieri, S, Siena, S, Bianco, R, Riccardi, F, Spatafora, M, Ravaioli, A, Felletti, R, Fregoni, V, Genestreti, G, Rossi, A, Mancuso, G, Fasano, M, Morabito, A, Tsao, M, Signoriello, S, Perrone, F, Gridelli, C

مصطلحات موضوعية: Advanced non-small-cell lung cancer, Chemotherapy, EGFR, Erlotinib, First-line treatment, Health-related quality of life, Randomized trial, Adenocarcinoma, Aged, Antineoplastic Combined Chemotherapy Protocol, Carcinoma, Large Cell, Non-Small-Cell Lung, Squamous Cell, Cisplatin, Deoxycytidine, Erlotinib Hydrochloride, Female, Follow-Up Studie, Human, Lung Neoplasm, Male, Neoplasm Recurrence, Local, Neoplasm Staging, Prognosi, Quinazoline, Research Design, Salvage Therapy, Surveys and Questionnaire

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/23154555; info:eu-repo/semantics/altIdentifier/wos/WOS:000311387700022; volume:7; issue:12; firstpage:1830; lastpage:1844; numberofpages:15; journal:JOURNAL OF THORACIC ONCOLOGY; http://hdl.handle.net/11591/320642Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84870327842

الإتاحة: https://doi.org/10.1097/JTO.0b013e318275b327Test
http://hdl.handle.net/11591/320642Test

المؤلفون: Gridelli C., Morgillo F., Favaretto A., de Marinis F., Chella A., Cerea G., Mattioli R., Tortora G., Rossi A., Fasano M., Pasello G., Ricciardi S., Maione P., di Maio M., Ciardiello F.

المساهمون: Gridelli, C., Morgillo, F., Favaretto, A., de Marinis, F., Chella, A., Cerea, G., Mattioli, R., Tortora, G., Rossi, A., Fasano, M., Pasello, G., Ricciardi, S., Maione, P., di Maio, M., Ciardiello, F.

مصطلحات موضوعية: Elderly, Erlotinib, Gemcitabine, NSCLC, Sorafenib, Adenocarcinoma, Bronchiolo-Alveolar, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocol, Benzenesulfonate, Carcinoma, Large Cell, Non-Small-Cell Lung, Squamous Cell, Deoxycytidine, Erlotinib Hydrochloride, Feasibility Studie, Female, Follow-Up Studie, Human, Lung Neoplasm, Male, Niacinamide, Phenylurea Compound, Pyridine, Quinazoline, Survival Rate, Treatment Outcome

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/21212155; info:eu-repo/semantics/altIdentifier/wos/WOS:000292048500008; volume:22; issue:7; firstpage:1528; lastpage:1534; numberofpages:7; journal:ANNALS OF ONCOLOGY; http://hdl.handle.net/11577/3368192Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-79959695837

الإتاحة: https://doi.org/10.1093/annonc/mdq630Test
http://hdl.handle.net/11577/3368192Test

المؤلفون: Floriana Morgillo, Giovanna Esposito, Gianfranco Mancuso, Francesco Perrone, Fortunato Ciardiello, Maria Carmela Piccirillo, Paolo Maione, Clorinda Schettino, Cesare Gridelli, Raimondo Di Liello, Piera Gargiulo, Vittorio Gebbia, Giuliano Palumbo, Massimo Di Maio, Adriano Gravina, Alessia Spagnuolo, Laura Arenare, Alessandro Morabito, Carminia Maria Della Corte, Ciro Gallo

المساهمون: Gargiulo, P., Arenare, L., Gridelli, C., Morabito, A., Ciardiello, F., Gebbia, V., Maione, P., Spagnuolo, A., Palumbo, G., Esposito, G., Della Corte, C. M., Morgillo, F., Mancuso, G., Di Liello, R., Gravina, A., Schettino, C., Di Maio, M., Gallo, C., Perrone, F., Piccirillo, M. C.

المصدر: BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Cancer

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Retrospective-prospective design, Lung Neoplasms, law.invention, Chemotherapy-induced neutropenia (CIN), Lung cancer, Overall survival, Prognostic factors, 0302 clinical medicine, Randomized controlled trial, law, Carcinoma, Non-Small-Cell Lung, Clinical endpoint, Prospective Studies, RC254-282, Randomized Controlled Trials as Topic, Prognostic factor, education.field_of_study, Hazard ratio, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, 030220 oncology & carcinogenesis, Female, medicine.medical_specialty, Neutropenia, Population, Antineoplastic Agents, 03 medical and health sciences, Internal medicine, Genetics, medicine, Humans, education, neoplasms, Aged, Retrospective Studies, Proportional hazards model, business.industry, Research, Cancer, medicine.disease, 030104 developmental biology, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56845084e8de5aa8b4753e0081aedf5cTest
https://doaj.org/article/a4ff3976bddf475882f1ba7ca7d1a374Test

المؤلفون: Carminia Maria Della Corte, Carl Michael Gay, Lauren Averett Byers, Floriana Morgillo

المساهمون: Della Corte, C. M., Gay, C. M., Byers, L. A., Morgillo, F.

المصدر: EBioMedicine

مصطلحات موضوعية: Male, Research paper, Signaling pathways, Lung Neoplasms, MAP Kinase Signaling System, Prognosi, Mutant, MEDLINE, Protein Tyrosine Phosphatase, Non-Receptor Type 11, Protein Serine-Threonine Kinases, NSCLC, General Biochemistry, Genetics and Molecular Biology, Cohort Studies, ErbB Receptors, Text mining, Src homology 2 domain-containing phosphatase 2, Carcinoma, Non-Small-Cell Lung, Carcinoma, Medicine, Humans, Integrin-linked kinase, ErbB Receptor, Lung cancer, Protein Kinase Inhibitors, Aged, Hepatocyte Growth Factor, Interleukin-6, business.industry, General Medicine, medicine.disease, Prognosis, EGFR mutations, Progression-Free Survival, Up-Regulation, Gene Expression Regulation, Neoplastic, Mutation, Cohort, Commentary, Cancer research, Regression Analysis, Female, Cohort Studie, business, Cohort study, Human

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4de1a5b26c9d16e9afcea0f7279f49dcTest
http://hdl.handle.net/11591/424046Test

المؤلفون: Marina Chiara Garassino, Annamaria Catino, Luana Calabrò, Francesca Ambrosio, Carmelo Bengala, Alessandro Follador, Fabiana Vitiello, Floriana Morgillo, Lucio Crinò, Paola Bordi, Enrico Mini, Giuseppe Lo Russo, Enrico Vasile, Andrea Ardizzoni, Antonio Santo, Federico Cappuzzo, Alessandro Scoppola, Giuseppe Altavilla, Diana Giannarelli, Enrico Cortesi, Natale Tedde, Fausto Barbieri

المساهمون: Garassino, M. C., Crino, L., Catino, A., Ardizzoni, A., Cortesi, E., Cappuzzo, F., Bordi, P., Calabro, L., Barbieri, F., Santo, A., Altavilla, G., Ambrosio, F., Mini, E., Vasile, E., Morgillo, F., Scoppola, A., Bengala, C., Follador, A., Tedde, N., Giannarelli, D., Lo Russo, G., Vitiello, F., Garassino, Marina Chiara, Crinò, Lucio, Catino, Annamaria, Ardizzoni, Andrea, Cortesi, Enrico, Cappuzzo, Federico, Bordi, Paola, Calabrò, Luana, Barbieri, Fausto, Santo, Antonio, Altavilla, Giuseppe, Ambrosio, Francesca, Mini, Enrico, Vasile, Enrico, Morgillo, Floriana, Scoppola, Alessandro, Bengala, Carmelo, Follador, Alessandro, Tedde, Natale, Giannarelli, Diana, Lo Russo, Giuseppe, Vitiello, Fabiana

المصدر: Tumor Biology, Vol 40 (2018)

مصطلحات موضوعية: Oncology, Male, Cancer Research, Lung Neoplasms, medicine.medical_treatment, never-smokers, carcinoma, Health Services Accessibility, Cohort Studies, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, 80 and over, Medicine, 030212 general & internal medicine, squamous non-small cell lung cancer, RC254-282, Aged, 80 and over, never-smoker, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, General Medicine, Middle Aged, Prognosis, expanded access program, italian, nivolumab, Survival Rate, Nivolumab, 030220 oncology & carcinogenesis, Cohort, Carcinoma, Squamous Cell, Disease Progression, Female, Case-Control Studie, Human, Cohort study, Expanded access program, italian, never-smokers, nivolumab, squamous non-small cell lung cancer, adult, aged, aged, 80 and over, carcinoma, non-small-cell lung, squamous cell, case-control studies, cohort studies, disease progression, female, follow-up studies, humans, lung neoplasms, male, middle aged, nivolumab, non-smokers, Prognosis, survival rate, health services accessibility, Adult, medicine.medical_specialty, Italian, Prognosi, Follow-Up Studie, 03 medical and health sciences, Internal medicine, Humans, Survival rate, Aged, squamous cell, Expanded access program, business.industry, Case-control study, Immunotherapy, Non-Smokers, Lung Neoplasm, non-small-cell lung, Non-Smoker, Expanded access, Case-Control Studies, Squamous non-small cell lung cancer, Cohort Studie, business, Follow-Up Studies

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20c642f7d451ab777c58a9f1fa409060Test
https://pubmed.ncbi.nlm.nih.gov/30486741Test

المؤلفون: Anna Zamboli, Andrea Mabilia, Paolo Castellano, Gennaro Galizia, Annamaria Auricchio, Ferdinando De Vita, Andrea Renda, Fortunato Ciardiello, Floriana Morgillo, Michele Orditura, Eva Lieto

المساهمون: Galizia, G., De Vita, F., Lieto, E., Zamboli, A., Morgillo, F., Renda, Andrea, Ciardiello, F., Orditura, M., Galizia, Gennaro, DE VITA, Ferdinando, Lieto, Eva, Zamboli, A, Morgillo, Floriana, Castellano, P, Mabilia, A, Aurichio, A, Renda, A, Ciardiello, Fortunato, Orditura, Michele

مصطلحات موضوعية: Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Colorectal cancer, medicine.medical_treatment, Antineoplastic Agents, Gastroenterology, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Hepatectomy, Humans, Prospective Studies, Prospective cohort study, Survival rate, Aged, Neoplasm Staging, Randomized Controlled Trials as Topic, Aged, 80 and over, Chemotherapy, Cetuximab, business.industry, Liver Neoplasms, Cancer, General Medicine, Middle Aged, medicine.disease, Combined Modality Therapy, Survival Rate, Female, Liver cancer, business, Colorectal Neoplasms, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0d99167f63462b6ab02fb0d665db8daTest
http://hdl.handle.net/11588/561351Test